1,005
Participants
Start Date
November 30, 2011
Primary Completion Date
March 31, 2014
Study Completion Date
April 30, 2014
SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion
One unit prestorage, leuko-depleted SAGM blood at haemoglobin at 9.0 g/dl (5.6 mM) or less at point-of-care testing
SAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion
One unit prestorage, leuko-depleted SAGM blood at haemoglobin 7.0 g/dl (4.3 mM) or less at point-of-care testing
Ålborg University Hospital, Aalborg
Aarhus University Hospital, NBG, Aarhus
Aarhus University Hospital, Skejby, Aarhus
Bispebjerg Hospital, Copenhagen
Glostrup Hospital, Copenhagen
Hvidovre Hospital, Copenhagen
Rigshospitalet, Copenhagen
Gentofte Hospital, Gentofte Municipality
Herning Hospital, Herning
Hjørring Hospital, Hjørring
Holbæk Hospital, Holbæk
Horsens Hospital, Horsens
Kolding Hospital, Kolding
Køge Hospital, Køge
Næstved Hospital, Næstved
Randers Hospital, Randers
Slagelse Hospital, Slagelse
Sønderborg Hospital, Sønderborg
Vejle Hospital, Vejle
Helsinki University Hospital, Helsinki
Joensuu Hospital, Joensuu
Tampere University Hospital, Tampere
Ålesund Hospital, Ålesund
Haukeland University Hospital, Bergen
Akershus University Hospital, Oslo
Stavanger University Hospital, Stavanger
Halmstad Hospital, Halmstad
Helsingborg Hospital, Helsingborg
Karolinska Hospital, Huddinge, Stockholm
Karolinska Institutet Solna, Stockholm
Södersjukhuset, Stockholm
Växjö Hospital, Vaxjo
Copenhagen Trial Unit, Center for Clinical Intervention Research
OTHER
Rigshospitalet, Denmark
OTHER
University of Copenhagen
OTHER
Scandinavian Critical Care Trials Group
OTHER